News about Global Pharma

CAI and Fedegari Group to Deliver Turnkey Sterilization Solutions to Pharma Manufacturers

CAI has inked a strategic partnership with Fedegari Group, a manufacturer and service provider of high-performance sterilization systems.

Global Pharma | 23/05/2024 | By Aishwarya |  386

Strides Announces Best-Ever Financial Results for FY24

Strides Pharma Science Ltd. has published its consolidated financial results for the quarter (Q4FY24) and full year (FY24) ended March 31, 2024.

Global Pharma | 23/05/2024 | By Aishwarya |  1565

LabGenius Raises EUR 35 Million to Develop its ML-Driven Antibody Discovery Platform

LabGenius, a drug discovery company pioneering the use of machine learning for the discovery of novel therapeutic antibodies, has secured EUR 35 million in Series B financing round.

Global Pharma | 23/05/2024 | By Aishwarya |  906

Dragonfly Therapeutics Partners with Merck to Evaluate DF9001

Dragonfly Therapeutics, Inc. has entered into a clinical collaboration with Merck (known as MSD outside the US and Canada), to evaluate DF9001, Dragonfly's EGFR immune engager, in combination with Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in patients with advanced solid tumors expressing EGFR.

Global Pharma | 22/05/2024 | By Aishwarya |  643

Valneva Names Dr. Hanneke Schuitemaker as Chief Scientific Officer

Valneva has appointed Dr. Hanneke Schuitemaker, PhD as Chief Scientific Officer (CSO) and Executive Committee member, effective June 3, 2024.

Global Pharma | 22/05/2024 | By Aishwarya |  554

PharmaLytica 2024 to Mark a Decade of Excellence and Innovation for Pharma Manufacturing

PharmaLytica Expo has been approaching its milestone 10th edition launch, scheduled from May 30, 2024 to June 1, 2024, at HITEX, Hyderabad a prominent pharmaceutical hub in India.

Global Pharma | 22/05/2024 | By Aishwarya |  1024

Tower Cold Chain Announces its First Sustainability Report

Tower Cold Chain has recently published its first Sustainability Report, highlighting the company’s commitment to Environmental, Social and Governance (ESG) principles.

Global Pharma | 22/05/2024 | By Aishwarya |  448

Glenmark Signs Exclusive Marketing and Distribution Deal with BeiGene

Glenmark has signed an exclusive marketing and distribution agreement with BeiGene, a global oncology company.

Global Pharma | 21/05/2024 | By Aishwarya |  1192

Biocon Biologics Gets FDA Approval for Biosimilar Aflibercept for Yesafili

Biocon Biologics Ltd (BBL) has announced that the US Food and Drug Administration (US FDA) has approved the company’s first-to-file application for Yesafili.

Global Pharma | 21/05/2024 | By Aishwarya |  647

Astellas Pharma and YASKAWA Sign MOU to Explore Innovative Cell Therapy Ecosystem

Astellas will contribute cell manufacturing technology, clinical development, and regulatory insights related to cell therapy, while YASKAWA will provide and develop robotics and factory automation technologies.

Global Pharma | 21/05/2024 | By Abha |  732